192 related articles for article (PubMed ID: 27828643)
1. Fixed drug eruption by etoricoxib confirmed by patch test.
Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
[TBL] [Abstract][Full Text] [Related]
2. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
Calistru AM; Cunha AP; Nogueira A; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
[TBL] [Abstract][Full Text] [Related]
3. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
Andrade P; Gonçalo M
Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
[No Abstract] [Full Text] [Related]
4. Fixed drug eruption and generalised erythema following etoricoxib.
Augustine M; Sharma P; Stephen J; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
[No Abstract] [Full Text] [Related]
5. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
Ponce V; Muñoz-Bellido F; Moreno E; Laffond E; González A; Dávila I
Contact Dermatitis; 2012 Feb; 66(2):107-8. PubMed ID: 22233472
[No Abstract] [Full Text] [Related]
6. Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing.
Gómez de la Fuente E; Pampín Franco A; Caro Gutiérrez D; López Estebaranz JL
Actas Dermosifiliogr; 2014 Apr; 105(3):314-5. PubMed ID: 24661957
[No Abstract] [Full Text] [Related]
7. Etoricoxib-induced fixed drug eruption: Report of seven cases.
Martínez Antón MD; Galán Gimeno C; Sánchez de Vicente J; Jáuregui Presa I; Gamboa Setién PM
Contact Dermatitis; 2021 Mar; 84(3):192-195. PubMed ID: 32666601
[TBL] [Abstract][Full Text] [Related]
8. Etoricoxib-induced erythema-multiforme-like eruption.
Thirion L; Nikkels AF; Piérard GE
Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
[TBL] [Abstract][Full Text] [Related]
9. Etoricoxib-induced acute generalized exanthematous pustulosis.
Mäkelä L; Lammintausta K
Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
[No Abstract] [Full Text] [Related]
10. Bullous Fixed Drug Eruption Caused by Etoricoxib Confirmed by Patch Testing.
Carneiro-Leão L; Rodrigues Cernadas J
J Allergy Clin Immunol Pract; 2019; 7(5):1629-1630. PubMed ID: 30777670
[No Abstract] [Full Text] [Related]
11. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
[No Abstract] [Full Text] [Related]
12. Bullous fixed drug eruption induced by etoricoxib, confirmed by patch testing, with tolerance to celecoxib.
Miroux-Catarino A; Silva L; Amaro C; Ferreira ML; Viana I
Contact Dermatitis; 2019 Nov; 81(5):388-389. PubMed ID: 31215658
[No Abstract] [Full Text] [Related]
13. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
[No Abstract] [Full Text] [Related]
14. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
15. Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report.
Perks A; Bates TJ; Velangi S; Brown RM; Poveda-Gallego A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Apr; 131(4):e100-e107. PubMed ID: 33468439
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
17. Mucosal exfoliation as a selective reaction to etoricoxib.
Patanè M; Isola S; Gangemi S; Minciullo PL
J Clin Pharm Ther; 2016 Dec; 41(6):722-724. PubMed ID: 27576781
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
Muratore L; Ventura M; Calogiuri G; Calcagnile F; Quarta E; Muratore M; Ferrannini A
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
[TBL] [Abstract][Full Text] [Related]
19. Neutrophilic Generalized Fixed Drug Eruption Induced by Etoricoxib.
Vera A; Freih A; Múgica MV; Vega F; Belver MT; Blanco C
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):517-519. PubMed ID: 33720837
[No Abstract] [Full Text] [Related]
20. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing.
Zedlitz S; Linzbach L; Kaufmann R; Boehncke WH
Contact Dermatitis; 2002 Jun; 46(6):352-3. PubMed ID: 12190624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
